Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Description

This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.

Conditions

Rectal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Condition
Rectal Cancer
Intervention / Treatment

-

Contacts and Locations

Cooperstown

Bassett Healthcare Network, Cooperstown, New York, United States, 13326

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18 or greater
  • 2. ECOG PS 0-2
  • 3. Stage II or III, newly diagnosed, biopsy proven, rectal cancer
  • 4. No prior treatment for rectal cancer
  • 5. No prior pelvic radiotherapy
  • 6. Willing to undergo study related testing and monitoring after treatment
  • 7. Women of childbearing potential must rule out pregnancy within 2 weeks prior to registration with a blood test or urine study
  • 8. Women must not be pregnant or breastfeeding
  • 9. Able to provide informed consent
  • 1. Patients with metastatic disease
  • 2. Patients that are not candidates for surgery
  • 3. Patients that refuse neoadjuvant treatment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Bassett Healthcare,

Eric Bravin, MD, PRINCIPAL_INVESTIGATOR, Bassett Healthcare

Study Record Dates

2027-08-01